Across Europe continent, authorities are increasingly alerted by the rise of fentanyl and its analogues, a highly potent synthetic opioid. Initially detected in certain regions, its presence is now documented in a broadening range of countries, from Belgium and Ireland to Germany. While overall usage rates remain below those seen in North America,

Belgium has officially introduced a new ketamine solution for mental health problems. This groundbreaking development represents a significant step forward in offering effective treatment alternatives for patients suffering from PTSD, among other ailments. The ketamine solution, administered intravenously, has shown positive results in research and